"19515-909-52" National Drug Code (NDC)

NDC Code	19515-909-52
Package Description	10 SYRINGE in 1 CARTON (19515-909-52) > .5 mL in 1 SYRINGE (19515-909-41)
Product NDC	19515-909
Product Type Name	VACCINE
Proprietary Name	Flulaval Quadrivalent
Proprietary Name Suffix	2018/2019
Non-Proprietary Name	Influenza Virus Vaccine
Dosage Form	SUSPENSION
Usage	INTRAMUSCULAR
Start Marketing Date	20180629
End Marketing Date	20190630
Marketing Category Name	BLA
Application Number	BLA125163
Manufacturer	ID Biomedical Corporation of Quebec
Substance Name	INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 IVR-186 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 BX-69A ANTIGEN (UV, FORMALDEHYDE INACTIVATED)
Strength	15; 15; 15; 15
Strength Unit	ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL